Ryvu Therapeutics S.A. (WSE:RVU)

Ryvu Therapeutics Revenue

In the year 2025, Ryvu Therapeutics had annual revenue of 87.70M PLN, down -13.98%. Ryvu Therapeutics had revenue of 25.78M in the quarter ending December 31, 2025, a decrease of -9.50%.

• Revenue: 87.70M
• Revenue Growth: -13.98%
• P/S Ratio: 5.97
• Revenue / Employee: 384.66K
• Employees: 228
• Market Cap: 523.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.70M	-14.26M	-13.98%
Dec 31, 2024	101.96M	34.67M	51.51%
Dec 31, 2023	67.30M	-1.14M	-1.67%
Dec 31, 2022	68.44M	33.02M	93.25%
Dec 31, 2021	35.41M	-1.54M	-4.16%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error